VIFOR PHARMA
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

VIFOR PHARMA Trademark

Serial Number: 79158397 • Registration: 4948439

VIFOR PHARMA is a trademark filed by Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.) on September 18, 2014. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.) (71 trademarks)

Rechenstrasse 37
St. Gall 9014 , CH

Entity Type: 03

Galenica AG (4 trademarks)

Untermattweg 8
CH-3001 Bern , CH

Entity Type: 99

Trademark Details

Filing Date

September 18, 2014

Registration Date

May 3, 2016

Published for Opposition

February 16, 2016

Cancellation Date

November 18, 2022

Goods & Services

Business training services as relating to pharmaceutical and sanitary products

Transport, storage, delivery, and packaging of goods, namely, medicines, pharmaceutical and sanitary preparations

Pharmaceutical preparations for the treatment and prevention of gastro-intestinal disorders, urinary tract disorders, kidney disorders, capillary hemorrhages, diabetic retinopathy, venous insufficiency; pharmaceutical preparations for the treatment of gastrointestinal discomforts and gastrointestinal diseases, iron deficiency, iron deficiency anemia, disorders of the central nervous system, ophthalmic diseases, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, diabetes and related diseases, and migraines and other forms of headache; Pharmaceutical products for the treatment of acute or chronic conditions or consequences of or associated with acute or chronic renal disease, such as acute renal insufficiency, intrinsic kidney disease, glomerulonephritis, tubular disorders and tubulointerstitial diseases, vasculitis of the kidney, vascular injury to the kidney, infection related kidney disorders, kidney neoplasms, congenital and genetic disorders, cystic disorders of the kidney, systemic diseases effecting the kidney, and toxin damage to the kidney; analgesics; antiviral; anti-infectives; anti-inflammatories; antibiotics; antidepressants; anti-cancer preparations; pharmaceutical preparations for use in organ and tissue transplantation; preparations for the treatment of immunologic diseases; pharmaceutical preparations for dialysis and conditions associated with dialysis; preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for treatment of water and electrolyte metabolism disorders and disorders associated with dialysis; medicated lotions for the skin and hair; decongestants and anti-histamines; preparations used as immune system stimulators; scabicides; anti-malarials; cough treatment preparations, namely, cough suppressants; preparations for treating coughs and colds; expectorants; anti-leukemic agents; dermatologicals; tissue sealants; vasopressors; pharmaceutical preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; preparations for the treatment of gout; preparations for cessation of smoking; preparations of treatment of Parkinson's disease; vaccines; antiemetics; nasal spray preparations; sanitary preparations for medical uses; parapharmaceutical products for use in dermatology; dietetic foods, namely, dietary supplement; preparations containing unsaturated fatty acids, vitamins and minerals, nutraceuticals for use as a dietary supplement adapted for medical use; food for babies; medical plasters; medical dressings; material for stopping teeth; dental wax; all-purpose disinfectants

Soaps, perfumery, essential oils, cosmetics, hair lotions; dentifrices

Import agency services in the field of medicines and pharmaceutical preparations; retail store services featuring pharmaceutical and sanitary preparations; import-export agencies in the fields of medicines, pharmaceutical and sanitary preparations

Legal services and legal representation of third parties to the authorities and administration with respect to approval of medicines

Research and development of medicines, pharmaceutical preparations and sanitary care products for others

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Mar 21, 2025 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Mar 21, 2025 INNA
GENERIC MADRID TRANSACTION CREATED
Mar 21, 2025 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 18, 2023 INTR
CANCELLED SECTION 71
Nov 18, 2022 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 30, 2021 NREP
INTERNATIONAL REGISTRATION RENEWED
Sep 13, 2018 RNWL
CHANGE OF OWNER RECEIVED FROM IB
Oct 5, 2017 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 17, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 9, 2016 FICS
FINAL DISPOSITION PROCESSED
Aug 9, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 3, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
May 3, 2016 R.PR
PUBLISHED FOR OPPOSITION
Feb 16, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Feb 12, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 27, 2016 OP2R
NOTICE OF PUBLICATION
Jan 27, 2016 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 13, 2016 PREV
EXAMINER'S AMENDMENT ENTERED
Jan 11, 2016 XAEC
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2016 XAEC
EXAMINERS AMENDMENT MAILED
Jan 7, 2016 CNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 7, 2016 CNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 6, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2016 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 5, 2016 ERFR
FINAL REFUSAL MAILED
Jul 9, 2015 CNFR
FINAL REFUSAL WRITTEN
Jul 8, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2015 CRFA
ASSIGNED TO LIE
Jun 1, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 27, 2015 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2015 REAP
REFUSAL PROCESSED BY IB
Feb 6, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 13, 2015 RFCS
REFUSAL PROCESSED BY MPU
Jan 13, 2015 RFRR
APPLICATION FILING RECEIPT MAILED
Jan 13, 2015 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 11, 2015 RFCR
NON-FINAL ACTION WRITTEN
Jan 10, 2015 CNRT
ASSIGNED TO EXAMINER
Jan 8, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2015 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 2, 2015 SDRC